Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005659700
Wed, 14.04.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 14 April 2021. Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite with a total area of around 270 m² will be a 21 CFR 211 compliant, radiopharmaceutical manufacturing facil [ … ]
Tue, 12.01.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 12 January 2021. Seed implantation for prostate cancer is now to be reimbursed as an outpatient treatment by public health insurances in Germany. This was decided by the Federal Joint Committee (G-BA) with effect from January 8, 2021.
Seed implantation or so called LDR brachytherapy is an organ-preserving, minimally invasive radiation proc [ … ]
Tue, 10.11.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 10 November 2020. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), a specialist for isotope applications in medicine, science and industry, again achieved a very strong result of EUR 17.7 million in the first nine months of 2020. Compared to the same period of the previous year, consolidated net income decre [ … ]
Tue, 25.08.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 25 August 2020. Eckert & Ziegler Radiopharma GmbH has received approval for its pharmaceutical 68Ge/68Ga generator GalliaPharm(R) from the Canadian regulatory authority Health Canada.
"We are pleased to now be able to offer GalliaPharm(R) in Canada. Meanwhile, the generators from Eckert & Ziegler are available in more and more coun [ … ]
Thu, 13.08.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 13 August 2020. Despite heavy burdens from corona and the drop in oil price, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), a specialist for isotope applications in medicine, science and industry, closed the first half of 2020 with a net income of 12.7 million EUR, almost reaching the record level of the p [ … ]
Thu, 30.07.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Press release
Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020
Berlin, 30 July 2020. Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) announces that the increase in share capital approved by the Annual General Meeting on 10 June 2020 has been registered in the commercial register a [ … ]